Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone for post-stroke dementia
ChiCTR-TRC-13003462Phase 4Recruiting
- Sponsor
- Army Specialized Medical Center
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of edaravone and donepezil in Post-stroke dementia (PSD), vascular dementia, mixed dementia and 1 more (6 arms), sponsored by Army Specialized Medical Center. Primary endpoints: Mini-Mental State Examination, Imaging detection and 6 more. Started Apr 2013; status: recruiting.
02
Drugs
edaravonedonepezil
03
Conditions
Post-stroke dementia (PSD)vascular dementiamixed dementiaAlzheimer's disease (AD)
Beyond the preview
Go deeper on ChiCTR-TRC-13003462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003462.